I'm looking forward to hearing the outcome of the ethics human trial submission for the teaching hospital for the burns application. For me, the great thing about pursuing all these different avenues concurrently isn't the increase in possible revenue streams (sepsis alone would be huge), it's the risk reduction. By pursing Covid, bacterial infections and topical concurrently it means only one needs to succeed for commercial success. Still need to jump through all the regulatory requirements but I feel RCE had great momentum at the moment.
I'm looking forward to hearing the outcome of the ethics human...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 32.0¢ | 30.0¢ | $25.76K | 82.29K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 13550 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 18938 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |